CIK 0001595097
- Non-accelerated filer
- Smaller reporting company
Corbus Pharmaceuticals Holdings, Inc.
Sign in to watch- Ticker
- CRBP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 464348039
- Phone
- +1 617-963-0103
- Business address
- 500 RIVER RIDGE DRIVE, NORWOOD, MA, 02062
- Former names
- SAV Acquisition Corp
- 4 Open-market buy Chief Medical Officer bought 1,389 shares at $7.20 ($10,001)
- 4 Open-market buy Chief Commercial Officer bought 1,000 shares at $7.23 ($7,227)
- 4 Open-market buy Chief Financial Officer bought 100 shares at $7.12 ($712)
- 4 Open-market buy Chief Executive Officer bought 995 shares at $6.99 ($6,955)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Director bought 2,000 shares at $6.98 ($13,958)
- 4 Open-market buy Director bought 1,000 shares at $6.98 ($6,978)
- 4 Open-market buy Chief Commercial Officer bought 5,000 shares at $6.85 ($34,259)
- 4 Open-market buy Chief Medical Officer bought 4,638 shares at $6.47 ($29,994)
- 4 Open-market buy Chief Financial Officer bought 1,500 shares at $6.67 ($10,005)
- 4 Open-market buy Chief Executive Officer bought 1,530 shares at $6.49 ($9,930)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Exercise or conversion President and CSO acquired 10,000 shares (option exercise)
- 4 Derivatives Options or other derivatives
Page 9 of 17 · 340 filings